Home > Insider Trading > Filing (0000899243-20-029693)

Filing Details

Accession Number:: 0000899243-20-029693
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-10-29 16:58:22
Reporting Period:: 2020-10-27

Accepted Time:: 2020-10-29 16:58:22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1822462	Foghorn Therapeutics Inc.	FHTX	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1222012	Noubar Afeyan	55 Cambridge Parkway, Suite 800E Cambridge MA	No	No	Yes	No
1400240	Flagship Pioneering Inc.	55 Cambridge Parkway, Suite 800E Cambridge MA 02142	No	No	Yes	No
1627639	Flagship Ventures Fund V, L.p.	55 Cambridge Parkway, Suite 800E Cambridge MA 02142	No	No	Yes	No
1677345	Flagship Ventures Opportunities Fund I, L.p.	55 Cambridge Parkway, Suite 800E Cambridge MA 02142	No	No	Yes	No
1724575	Flagship Ventures Fund V General Partner Llc	55 Cambridge Parkway, Suite 800E Cambridge MA 02142	No	No	Yes	No
1725004	Flagship Ventures Opportunities Fund I General Partner Llc	55 Cambridge Parkway, Suite 800E Cambridge MA 02142	No	No	Yes	No
1761283	Flagship Pioneering Special Opportunities Fund Ii, L.p.	55 Cambridge Parkway, Suite 800E Cambridge MA 02142	No	No	Yes	No
1826217	Flagship Pioneering Special Opportunities Fund Ii General Partner Llc	55 Cambridge Parkway, Suite 800E Cambridge MA 02142	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-10-27	4,054,054	$0.00	4,054,054	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2020-10-27	4,504,504	$0.00	8,558,558	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2020-10-27	722,320	$0.00	9,280,878	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2020-10-27	50,000	$16.00	9,330,878	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2020-10-27	1,441,441	$0.00	1,441,441	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2020-10-27	50,000	$16.00	1,491,441	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2020-10-27	1,801,801	$0.00	1,801,801	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2020-10-27	50,000	$16.00	1,851,801	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A-1 Convertible Preferred Stock	Disposition	2020-10-27	7,500,000	$0.00	4,054,054	$0.00
Common Stock	Series A-2 Convertible Preferred Stock	Disposition	2020-10-27	8,333,333	$0.00	4,504,504	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2020-10-27	1,336,293	$0.00	722,320	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2020-10-27	2,666,666	$0.00	1,441,441	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2020-10-27	3,333,333	$0.00	1,801,801	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

The Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, and Series B Convertible Preferred Stock (collectively, the "Preferred Stock") is convertible into the number of shares of the Registrant's common stock shown in Table II, column 7 and has no expiration date. The Preferred Stock automatically converted into common stock upon the closing of the Registrant's initial public offering, which occurred on October 27, 2020.
Shares held by Flagship Ventures Fund V, L.P. ("Flagship Fund V"). Flagship Ventures Fund V General Partner LLC ("Fund V GP") is the general partner of Flagship Fund V. Noubar B. Afeyan Ph.D. serves as the sole manager of Fund V GP. Each of Fund V GP and Noubar B. Afeyan Ph.D. disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
Shares held by Flagship Ventures Opportunities Fund I, L.P. ("Flagship Opportunities Fund I"). Flagship Ventures Opportunities Fund I General Partner LLC ("Opportunities Fund I GP") is the general partner of Flagship Opportunities Fund I. Noubar B. Afeyan Ph.D. serves as the sole manager of Opportunities Fund I GP. Each of Opportunities Fund I GP and Noubar B. Afeyan Ph.D. disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.
Shares held by Flagship Pioneering Special Opportunities Fund II, L.P. ("Flagship Opportunities Fund II"). Flagship Pioneering Special Opportunities Fund II General Partner LLC ("Opportunities Fund II GP") is the general partner of Flagship Opportunities Fund II. Flagship Pioneering, Inc. ("Flagship Pioneering") is the manager of Opportunities Fund II GP. Noubar B. Afeyan, Ph.D. is sole director of Flagship Pioneering. Each of Noubar B. Afeyan Ph.D., Flagship Pioneering, and Opportunities Fund II GP disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.